Papers: 8 Oct 2012 - 15 Oct 2012
Design and screening of a glial cell-specific, cell penetrating Peptide for therapeutic applications in multiple sclerosis.
Epstein-Barr virus Peptide Presented by HLA-E is Predominantly Recognized by CD8(bright) Cells in multiple Sclerosis Patients.
Disease-modifying drugs for multiple sclerosis must be globally available according to therapeutic guidelines suitable to different regions of the world.
Natalizumab may reduce cognitive changes and brain atrophy rate in relapsing-remitting multiple sclerosis: a prospective, non-randomized pilot study.
Latin American algorithm for treatment of relapsing-remitting multiple sclerosis using disease-modifying agents.
Clinical response to interferon beta and glatiramer acetate in multiple sclerosis patients: a Brazilian cohort.
Functional impairments in white matter syndrome of neuropsychiatric systemic lupus erythematosus are similar to those observed in patients with multiple sclerosis.
Physical rehabilitation interventions in nonambulatory people with multiple sclerosis: a systematic review.
Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM.
Cyclosporine in the treatment of a case of fulminant and refractory acute disseminated encephalomyelitis.
Prevalence and Significant Determinants of Post-traumatic Stress Disorder in a Large Sample of Patients with Multiple Sclerosis.
Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody.
Epitope-specific CD8+ T cells play a differential pathogenic role in the development of a viral disease model for multiple sclerosis.
Type D, anxiety and depression in association with quality of life in patients with Parkinson's disease and patients with multiple sclerosis.
Effect of vibration stimulation on dysbasia of spastic paraplegia in neuromyelitis optica: a possible example of neuronal plasticity.
Cerebral venous thrombosis after lumbar puncture and intravenous high dose corticosteroids: A case report of a childhood multiple sclerosis.
mTOR kinase, a key player in the regulation of glial functions: Relevance for the therapy of multiple sclerosis.
FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosis.
Multicontrast MR Imaging at 7T in Multiple Sclerosis: Highest Lesion Detection in Cortical Gray Matter with 3D-FLAIR.
Commercially available accelerometry as an ecologically valid measure of ambulation in individuals with multiple sclerosis.
Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex(R)) in people with multiple sclerosis: a new approach.
Exacerbation of Experimental Autoimmune Encephalomyelitis in the Absence of Breast Regression Protein 39/Chitinase 3-Like 1.
Disease mechanisms in MS: Cell adhesion molecule MCAM on pathogenic T cells-a green light for CNS entry in multiple sclerosis.
Estrogen treatment of experimental autoimmune encephalomyelitis requires E2 receptor positive B cells that upregulate PD-1 on CD4(+) Foxp3(+) Treg cells.
Extra-hippocampal subcortical limbic involvement predicts episodic recall performance in multiple sclerosis.
Interferon-beta-induced pulmonary sarcoidosis in a 30-year-old woman treated for multiple sclerosis: a case report.
Protective Effects of 7,8-Dihydroxyflavone on Retinal Ganglion and RGC-5 Cells Against Excitotoxic and Oxidative Stress.
Regional Heterogeneity of Cuprizone-Induced Demyelination: Topographical Aspects of the Midline of the Corpus Callosum.
Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study.
Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.
"Response to the Commentary on "Neuromyelitis Optica: Potential Roles for Intravenous Immunoglobulin"
Chronic cladribine administration increases amyloid Beta Peptide generation and plaque burden in mice.
Low vitamin B12 levels and gastric parietal cell antibodies in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders.